SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001564590-17-025157
Filing Date
2017-12-20
Accepted
2017-12-20 17:21:21
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1 vktx-s1_20171231.htm S-1 632053
2 EX-5.1 vktx-ex51_6.htm EX-5 24278
3 EX-23.1 vktx-ex231_7.htm EX-23 4020
4 GRAPHIC g201712202152287063941.jpg GRAPHIC 2494
5 GRAPHIC g201712202152291433942.jpg GRAPHIC 2494
6 GRAPHIC g201712202152291583943.jpg GRAPHIC 2494
7 GRAPHIC g201712202152447512707.jpg GRAPHIC 3305
8 GRAPHIC g201712202152493142708.jpg GRAPHIC 3305
  Complete submission text file 0001564590-17-025157.txt   681546
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-222202 | Film No.: 171267488
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences